Prof. Dr. Jerzy Adamski is a worldwide renowned expert in endocrinology and metabolomics, who is currently Head of the Research Unit - Molecular Endocrinology and Metabolism (MEM) at the Helmholtz Zentrum München in Neuherberg, Germany, and Chief Science Officer at Metaron-Diagnostics i.G. He studied Biochemistry Max Planck Institute of Experimental Endocrinology, Hannover and received his PhD in 1983. In 1995, he habilitated in Biochemistry at the Medical Academy of Hanover, University of Hannover in Germany. He has been working in the field of endocrine-related cancers and frequent human diseases like diabetes for 20 years. He published 436 papers (e.g. Nature Genetics, 2010; Nature 2011 and 2020; Nature Reviews in Nephrology, 2017; Cell, 2018 and 2021) holds several patents and has H-index of 68. He acts as an Editor-in-Chief for J. Steroid Biochemistry and Molecular Biology (IF 4.0). He developed prototypes for early diagnosis of endometriosis, diabetes type 2, kidney dysfunction and cardiovascular complications. Recently he edited and co-authored a book “Metabolomics for biomedical research” (ISBN ISBN: 978-0-12-812784-1) published in 2020. He is also a member of the Endocrine Society (USA), Metabolomics Society, German Society for Metabolomics Research